Recent Publications
Mimosa, ML, Al-Ameri, W, Simpson, JT, Nakhla, M, Boissinot, K, Munoz, DG et al.. A Novel Approach to Detect IDH Point Mutations in Gliomas Using Nanopore Sequencing: Test Validation for the Clinical Laboratory. J Mol Diagn. 2023;25 (3):133-142. doi: 10.1016/j.jmoldx.2022.12.001. PubMed PMID:36565986 .
Al-Obaidy, KI, Saleeb, RM, Trpkov, K, Williamson, SR, Sangoi, AR, Nassiri, M et al.. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity. Mod Pathol. 2022;35 (9):1279-1286. doi: 10.1038/s41379-022-01018-6. PubMed PMID:35152262 .
Saleeb, RM, Brimo, F, Gao, Y, Boulos, C, Kim, SS, Al Bashir, S et al.. ABCC2 expression in papillary renal cell carcinoma provides better prognostic stratification than WHO/ISUP nucleolar grade. Hum Pathol. 2022;120 :57-70. doi: 10.1016/j.humpath.2021.12.006. PubMed PMID:34958810 .
Lin, H. S., Ding, Q., Lichner, Z., Kim, S. S., Saleeb, R., Farag, M., Di Meo, A., Plant, P., Kaldas, M., Bjarnason, G. A., & Yousef, G. M. (2022). The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance. Journal of clinical medicine, 11(2), 369. https://doi.org/10.3390/jcm11020369
Thoeni, C, Ordon, M, Krizova, A, Jakate, K, Saleeb, RM. Perinephric myxoid pseudotumour of fat - first described case in allograft kidney, a mimicker of malignancy. Histopathology. 2021;79 (6):1108-1110. doi: 10.1111/his.14382. PubMed PMID:33835530 .
Trpkov, K, Williamson, SR, Gill, AJ, Adeniran, AJ, Agaimy, A, Alaghehbandan, R et al.. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34 (5):1037. doi: 10.1038/s41379-021-00775-0. PubMed PMID:33727698 .
Trpkov, K, Hes, O, Williamson, SR, Adeniran, AJ, Agaimy, A, Alaghehbandan, R et al.. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34 (7):1392-1424. doi: 10.1038/s41379-021-00779-w. PubMed PMID:33664427 .
Trpkov, K, Williamson, SR, Gill, AJ, Adeniran, AJ, Agaimy, A, Alaghehbandan, R et al.. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34 (6):1167-1184. doi: 10.1038/s41379-021-00737-6. PubMed PMID:33526874 .
Hodgson, A., van Rhijn, B. W. G., Kim, S. S., Ding, C., Saleeb, R., Vesprini, D., Liu, S. K., Yousef, G. M., van der Kwast, T. H., Xu, B., & Downes, M. R. (2020). Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. Pathology, research and practice, 216(11), 153186. https://doi.org/10.1016/j.prp.2020.153186
Saleeb, RM, Farag, M, Ding, Q, Downes, M, Bjarnason, G, Brimo, F et al.. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. Am J Pathol. 2019;189 (10):2046-2060. doi: 10.1016/j.ajpath.2019.07.002. PubMed PMID:31381885 .
Lichner, Z., Saleeb, R., Butz, H., Ding, Q., Nofech-Mozes, R., Riad, S., Farag, M., Varkouhi, A. K., Dos Santos, C. C., Kapus, A., & Yousef, G. M. (2019). Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(1), 1347–1359. https://doi.org/10.1096/fj.201800596R
Saleeb, R., Kim, S. S., Ding, Q., Scorilas, A., Lin, S., Khella, H. W., Boulos, C., Ibrahim, G., & Yousef, G. M. (2019). The miR-200 family as prognostic markers in clear cell renal cell carcinoma. Urologic oncology, 37(12), 955–963. https://doi.org/10.1016/j.urolonc.2019.08.008
Saleeb, RM, Farag, M, Lichner, Z, Brimo, F, Bartlett, J, Bjarnason, G et al.. Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy. Mol Oncol. 2018;12 (10):1673-1688. doi: 10.1002/1878-0261.12346. PubMed PMID:29896907 PubMed Central PMC6165997 .
Saleeb, R. M., Plant, P., Tawedrous, E., Krizova, A., Brimo, F., Evans, A. J., Wala, S. J., Bartlett, J., Ding, Q., Boles, D., Rotando, F., Farag, M., & Yousef, G. M. (2018). Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy. European urology focus, 4(5), 740–748. https://doi.org/10.1016/j.euf.2016.09.002
Saleeb, RM, Brimo, F, Farag, M, Rompré-Brodeur, A, Rotondo, F, Beharry, V et al.. Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis. Am J Surg Pathol. 2017;41 (12):1618-1629. doi: 10.1097/PAS.0000000000000962. PubMed PMID:28984673 .
Saleeb, R. M., Srigley, J. R., Sweet, J., Doucet, C., Royal, V., Chen, Y. B., Brimo, F., & Evans, A. (2017). Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors. Pathology, research and practice, 213(11), 1412–1418. https://doi.org/10.1016/j.prp.2017.08.004
Di Meo, A., Saleeb, R., Wala, S. J., Khella, H. W., Ding, Q., Zhai, H., Krishan, K., Krizova, A., Gabril, M., Evans, A., Brimo, F., Pasic, M. D., Finelli, A., Diamandis, E. P., & Yousef, G. M. (2017). A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization. Oncotarget, 9(2), 2092–2104. https://doi.org/10.18632/oncotarget.23162